Ventricular Tachycardia Ablation and Myocardial Scar Characterization With Magnetic Resonance

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

Also called NCT04694079

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 104 participants (enrolled count) (from the registry)
Sponsor
Azienda Ospedaliero, Universitaria Pisana (from the registry)
Registry
  • NCT NCT04694079
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04694079. Randomized; no masking; primary purpose treatment. Start 2020-08-03 (actual); primary completion 2025-07-17 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ventricular Tachycardia Ablation and Myocardial Scar Characterization With Magnetic Resonance
Acronym
VOYAGE
Condition
Ventricular Tachycardia
Condition
Myocardial Fibrosis
Intervention (Procedure)
Group 1, CMR-guided/aided VT ablation
Intervention (Procedure)
Group 2, CMR-aided VT ablation
Intervention (Procedure)
Group 3, Electroanatomical guided ablation
Lead sponsor
Azienda Ospedaliero, Universitaria Pisana (class: other)
Collaborator
Azienda USL Toscana Nord Ovest (class: other)
Collaborator
Azienda USL Toscana Sud Est (class: other government)
Collaborator
Azienda Ospedaliera Universitaria Senese (class: other)
Collaborator
Fondazione Toscana Gabriele Monasterio (class: other)
Collaborator
Centro Medico Teknon (class: other)

Record details

Record id
cardio:ct-nct04694079
Content hash
b6668ea8064ea52b9996495c66b0d5c778679768f7ca5fe4be016634c67ee190